These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 22982606)
1. Speech acoustic markers of early stage and prodromal Huntington's disease: a marker of disease onset? Vogel AP; Shirbin C; Churchyard AJ; Stout JC Neuropsychologia; 2012 Dec; 50(14):3273-8. PubMed ID: 22982606 [TBL] [Abstract][Full Text] [Related]
2. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data. Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR; Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844 [TBL] [Abstract][Full Text] [Related]
3. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. Tabrizi SJ; Scahill RI; Durr A; Roos RA; Leavitt BR; Jones R; Landwehrmeyer GB; Fox NC; Johnson H; Hicks SL; Kennard C; Craufurd D; Frost C; Langbehn DR; Reilmann R; Stout JC; Lancet Neurol; 2011 Jan; 10(1):31-42. PubMed ID: 21130037 [TBL] [Abstract][Full Text] [Related]
4. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data. Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR; Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354 [TBL] [Abstract][Full Text] [Related]
5. Prefrontal executive function associated coupling relates to Huntington's disease stage. Unschuld PG; Liu X; Shanahan M; Margolis RL; Bassett SS; Brandt J; Schretlen DJ; Redgrave GW; Hua J; Hock C; Reading SA; van Zijl PC; Pekar JJ; Ross CA Cortex; 2013; 49(10):2661-73. PubMed ID: 23906595 [TBL] [Abstract][Full Text] [Related]
6. Listener Detection of Objectively Validated Acoustic Features of Speech in Huntington's Disease. Chan JCS; Stout JC; Shirbin CA; Vogel AP J Huntingtons Dis; 2022; 11(1):71-79. PubMed ID: 34974436 [TBL] [Abstract][Full Text] [Related]
7. Visual Working Memory Impairment in Premanifest Gene-Carriers and Early Huntington's Disease. Dumas EM; Say MJ; Jones R; Labuschagne I; O'Regan AM; Hart EP; van den Bogaard SJ; Queller S; Justo D; Coleman A; Dar Santos RC; Dürr A; Leavitt BR; Tabrizi SJ; Roos RA; Stout JC J Huntingtons Dis; 2012; 1(1):97-106. PubMed ID: 25063192 [TBL] [Abstract][Full Text] [Related]
8. Speech biomarkers in Huntington's disease: A cross-sectional study in pre-symptomatic, prodromal and early manifest stages. Kouba T; Frank W; Tykalova T; Mühlbäck A; Klempíř J; Lindenberg KS; Landwehrmeyer GB; Rusz J Eur J Neurol; 2023 May; 30(5):1262-1271. PubMed ID: 36732902 [TBL] [Abstract][Full Text] [Related]
9. Speech in prodromal and symptomatic Huntington's disease as a model of measuring onset and progression in dominantly inherited neurodegenerative diseases. Chan JCS; Stout JC; Vogel AP Neurosci Biobehav Rev; 2019 Dec; 107():450-460. PubMed ID: 31419452 [TBL] [Abstract][Full Text] [Related]
10. Language disintegration in spontaneous speech in Huntington's disease: a more fine-grained analysis. Tovar A; Garí Soler A; Ruiz-Idiago J; Mareca Viladrich C; Pomarol-Clotet E; Rosselló J; Hinzen W J Commun Disord; 2020; 83():105970. PubMed ID: 32062158 [TBL] [Abstract][Full Text] [Related]
15. The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease. Russell DS; Barret O; Jennings DL; Friedman JH; Tamagnan GD; Thomae D; Alagille D; Morley TJ; Papin C; Papapetropoulos S; Waterhouse RN; Seibyl JP; Marek KL JAMA Neurol; 2014 Dec; 71(12):1520-8. PubMed ID: 25322077 [TBL] [Abstract][Full Text] [Related]
16. A systematic linguistic profile of spontaneous narrative speech in pre-symptomatic and early stage Huntington's disease. Hinzen W; Rosselló J; Morey C; Camara E; Garcia-Gorro C; Salvador R; de Diego-Balaguer R Cortex; 2018 Mar; 100():71-83. PubMed ID: 28859906 [TBL] [Abstract][Full Text] [Related]
17. Language-Independent Acoustic Biomarkers for Quantifying Speech Impairment in Huntington's Disease. Fahed VS; Doheny EP; Collazo C; Krzysztofik J; Mann E; Morgan-Jones P; Mills L; Drew C; Rosser AE; Cousins R; Witkowski G; Cubo E; Busse M; Lowery MM Am J Speech Lang Pathol; 2024 May; 33(3):1390-1405. PubMed ID: 38530396 [TBL] [Abstract][Full Text] [Related]
18. Psychomotor, executive, and memory function in preclinical Huntington's disease. Snowden JS; Craufurd D; Thompson J; Neary D J Clin Exp Neuropsychol; 2002 Apr; 24(2):133-45. PubMed ID: 11992196 [TBL] [Abstract][Full Text] [Related]
19. Abnormal Electrophysiological Motor Responses in Huntington's Disease: Evidence of Premanifest Compensation. Turner LM; Croft RJ; Churchyard A; Looi JC; Apthorp D; Georgiou-Karistianis N PLoS One; 2015; 10(9):e0138563. PubMed ID: 26406226 [TBL] [Abstract][Full Text] [Related]
20. Impaired postural stability as a marker of premanifest Huntington's disease. Salomonczyk D; Panzera R; Pirogovosky E; Goldstein J; Corey-Bloom J; Simmons R; Gilbert PE Mov Disord; 2010 Oct; 25(14):2428-33. PubMed ID: 20818666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]